Adult Dosing for Nightmare Disorder Medications
For PTSD-associated nightmares, start prazosin at 1 mg at bedtime and titrate by 1-2 mg every few days until effective, with typical doses ranging from 3-13 mg/day. 1
Prazosin Dosing (Primary Pharmacologic Option)
Prazosin is the most prominently studied medication for nightmare disorder and has the strongest evidence base 2. The dosing strategy is:
- Starting dose: 1 mg at bedtime
- Titration: Increase by 1-2 mg every few days based on response
- Typical effective dose: Approximately 3 mg/day
- Dose range: 1-16 mg/day (higher doses of 9.5-13.3 mg/day were used in PTSD-associated nightmares) 1
Critical monitoring: Watch for orthostatic hypotension throughout treatment 1. This is the primary safety concern that limits dosing.
The evidence shows prazosin reduces trauma-related nightmares as measured by CAPS Item B2 scores, with initial ratings of 4.8-6.9 dropping to 3.2-3.6 after treatment 1. Treatment duration in trials ranged from 3-9 weeks, though clinical use may be longer.
Alternative Pharmacologic Options
For PTSD-Associated Nightmares (May Be Used):
Cyproheptadine:
- Dose: 4-12 mg at bedtime 3
- Alternative studies suggest 16-24 mg orally at night for combat nightmares 4
- Response varies from complete remission to decreased intensity/frequency
Atypical Antipsychotics: 2
- Olanzapine, risperidone, aripiprazole (specific doses not provided in guidelines)
Other agents (doses not specified in guidelines): 2
- Clonidine
- Fluvoxamine
- Gabapentin
- Nabilone
- Phenelzine
- Topiramate
- Trazodone
- Tricyclic antidepressants
For Non-PTSD Nightmare Disorder (May Be Used):
Benzodiazepines: 2
- Nitrazepam (dose not specified)
- Triazolam (dose not specified)
- Prazosin (same dosing as above)
Medications NOT Recommended
Avoid these agents for nightmare disorder: 2
- Clonazepam
- Venlafaxine
These are explicitly not recommended based on AASM position statements.
Clinical Decision Algorithm
First-line approach: Image rehearsal therapy (behavioral intervention) is the only "recommended" treatment 2
Pharmacologic augmentation: When medication is needed:
If prazosin fails or is not tolerated: Consider cyproheptadine (4-24 mg at bedtime) or other "may be used" agents 3, 4
Important Caveats
The evidence limitation: The 2018 AASM position paper explicitly notes it is NOT a clinical practice guideline due to limited direct evidence for many treatments 2. Most medications carry only "may be used" designations, meaning evidence is less clear.
Concurrent therapy: In clinical trials, patients maintained ongoing psychotherapy and other psychotropic medications during prazosin treatment 1. Medication should complement, not replace, behavioral interventions.
Monitoring requirements: Beyond orthostatic hypotension with prazosin, general psychiatric monitoring is essential as nightmare disorder significantly impairs quality of life and can exacerbate underlying psychiatric conditions 1.